Other languages MediPharm Labs Corp.

Equities

LABS

CA58504D1006

Delayed Toronto S.E. Other stock markets 03:46:00 2024-04-23 pm EDT			5-day change	1st Jan Change
0.075 ^CAD	0.00%		-6.25%	+15.38%

Mar. 27	MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	MT
Mar. 27	MediPharm Labs Narrows Q4 Loss, Revenue Grows	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	Mar. 27
MediPharm Labs Narrows Q4 Loss, Revenue Grows	Mar. 27
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6%	Mar. 25
MediPharm Labs Provides Update on German Cannabis Legalization	Mar. 25
MediPharm Labs Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Tilray Brands, Inc. acquired 1000652011 Ontario Inc. from MediPharm Labs Corp. for CAD 8.5 million.	23-10-03
MediPharm Labs Jumps Near 7% As Launches New Products In Australia	23-09-27
MediPharm Labs Corp. Launches New GMP Products to the Australian Medical Cannabis Market	23-09-27
MediPharm Labs Corp. On Rescheduling of Cannabis	23-09-07
Medipharm Labs Corp. Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients	23-08-31
MediPharm Labs Narrows Q2 Loss, Revenue Grows; Up Over 6%	23-08-14
MediPharm Labs Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
MediPharm Labs Corp. Provides Update on US FDA Status	23-08-01
Avicanna Inc. and Medipharm Labs Inc. Expand Strategic Manufacturing Agreement for Avicanna's Proprietary Sedds Technology Capsules for Canadian and International Markets	23-06-26
MediPharm Labs' Q1 Loss Narrows, Revenue Rises	23-05-15
MediPharm Labs Seeks Acquisitions	23-05-15
MediPharm Labs Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
MediPharm Labs Corp. completed the acquisition of VIVO Cannabis Inc. from directors and officers of VIVO and others.	23-03-31
MediPharm Labs' Q4 Loss Narrows, Revenue Drops	23-03-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages MediPharm Labs Corp.

Equities

LABS

CA58504D1006

Other languages

Filters